しらべベース / 全サイトを探す米国特許しらべの条件検索・比較保存範囲・台帳
米国特許しらべ

Extension of the Cancer Immunotherapy Pilot Program

On June 29, 2016, the United States Patent and Trademark Office (USPTO) implemented the Cancer Immunotherapy Pilot Program, which permits patent applications pertaining to cancer immunotherapy to be advanced out of turn for examination and reviewed earlier (accorded special status). To date, over 80 petitions requesting participation in the pilot program have been filed, and 9 patents have been granted under the pilot program. Various stakeholders from around the world have filed petitions to participate in the pilot program--they are independent inventors, universities, research institutions, hospitals, medical centers, government agencies, and large and small companies. The pilot program was originally scheduled to end on June 28, 2017. In view of the continued interest in the pilot program, the USPTO is extending the pilot program until December 31, 2018. All pilot parameters will remain the same as the original pilot.

Task
Read the news
Patent or trademark
both
Legacy system
—
Current entry point
www.federalregister.gov/documents/2017/06/23/2017-13122/extension-of-the-cancer-immunotherapy-pilot-program (permanent link in the Federal Register, verified 2026-09-30)
Legacy system and where it moved
No legacy system name mention in title or summary )
Fee
No fee mention in title or summary )
What you need (account or API key)
No account or key mention in title or summary )
Published
2017-06-23
Document type
Notice
Source
USPTO documents published in the Federal Register (Federal Register API)(retrieved 2026-10-06)

Everything in the same category

Read the news (all 1988) · both (all 2333)

Related entry points

All USPTO service